Theorem Clinical Research

JLL Partners

DPx launched by JLL Partners, Royal DSM

Wednesday, March 12, 2014 01:43 PM

JLL Partners and Royal DSM have launched DPx Holdings, a global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries.

More... »

Quest Diagnostics

Water Street, JLL complete merger of CCBR-SYNARC, BioClinica

Wednesday, March 12, 2014 01:37 PM

Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry, and JLL Partners, a middle-market private equity firm, have merged their companies CCBR-SYNARC and BioClinica. The combination creates a global provider of specialty outsourced clinical services.

More... »


Royal DSM, JLL create jointly owned CDMO

Wednesday, November 20, 2013 12:48 PM

JLL Partners, a middle-market private equity firm, and Royal DSM, a global life sciences and materials sciences company, have created a new global contract development and manufacturing organization (CDMO) for the pharmaceutical industry, with anticipated sales of around $2 billion. It will be 51% owned by JLL and 49% owned by DSM.

More... »

JLL Partners Completes Acquisition of PharmaNet

Tuesday, March 31, 2009 09:36 AM

Contract research organization (CRO) PharmaNet is officially a private company after private equity firm JLL Partners completed its acquisition of the CRO yesterday.

More... »

JLL Partners Extends Deadline for Tender Offer of PharmaNet Shares

Friday, March 13, 2009 12:00 PM

PharmaNet Development Group stockholders have another week to tender their shares as part of the contract research organization (CRO)’s pending acquisition by private equity firm JLL Partners.

More... »

PharmaNet Launches Clinical Trial Staffing Service

Thursday, March 12, 2009 09:00 AM

Despite a pending acquisition by private equity firm JLL Partners, contract research organization (CRO) PharmaNet continues to expand its service offerings and locations.

More... »

PharmaNet Earnings Plummet in Q4

Thursday, February 26, 2009 11:23 AM

In what could be PharmaNet Development Group’s last earnings release as a public company, the contract research organization (CRO) reported its 2008 financial information late last night without an investor conference call.

More... »

PharmaNet to Open Brazil Office

Thursday, February 19, 2009 09:00 AM

PharmaNet Development Group is expanding its presence in Latin America with the opening of a new office in Sao Paulo, Brazil.

More... »

PharmaNet to Go Private in $250M Deal

Tuesday, February 3, 2009 10:04 AM

PharmaNet Development Group signed a definitive merger agreement with private equity firm JLL Partners, a deal that will make the now public contract research organization (CRO) a private company.

More... »


CWWeekly

March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs